Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K Hirtenlehner
Conversion of the Major Birch Pollen Allergen, Bet v 1, Into Two Nonanaphylactic T Cell Epitope-Containing Fragments: Candidates for a Novel Form of Specific Immunotherapy.
Journal of Clinical Investigation
Medicine
Related publications
Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 Is Isoform Dependent
PLoS ONE
Multidisciplinary
Seven Different Genes Encode a Diverse Mixture of Isoforms of Bet v 1, the Major Birch Pollen Allergen
BMC Genomics
Biotechnology
Genetics
Fast Generation of IgE, IgG1 and IgG4 by PIPE Cloning Sharing the Same Variable Region to the Major Birch Pollen Allergen Bet v 1
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Specific Immunotherapy Modifies Allergen-Specific CD4+ T-Cell Responses in an Epitope-Dependent Manner
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Immunogold Electron Microscopy of Soluble Proteins: Localization of Bet v I Major Allergen in Ultra-Thin Sections of Birch Pollen After Anhydrous Fixation Techniques.
Journal of Histochemistry and Cytochemistry
Anatomy
Histology
Birch Pollen Allergen Immunotherapy Reprograms Nasal Epithelial Transcriptome and Recovers Microbial Diversity
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Effect of Allergen-Specific Immunotherapy on CD4+ T Cells
Current Opinion in Allergy and Clinical Immunology
Allergy
Immunology
Sublingual Allergen Immunotherapy With a Liquid Birch Pollen Product in Seasonal Allergic Rhinoconjunctivitis With/Without Asthma*
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Allergen-Specific Immunotherapy
Allergy, Asthma and Clinical Immunology
Immunology
Pulmonary
Allergy
Respiratory Medicine
